Law & Medicine

Complementary and alternative medicine


 

Dr. Tan is emeritus professor of medicine and former adjunct professor of law at the University of Hawaii, Honolulu. This article is modified from a chapter in the author’s book, “Medical Malpractice: Understanding the Law, Managing the Risk.” It is meant to be educational and does not constitute medical, ethical, or legal advice. For additional information, readers may contact the author at siang@hawaii.edu.

References

1. Wengel v. Herfert, 473 N.W.2d 741 (1991).

2. Salazar v. Ehmann, 505 P.2d 387 (1972).

3. Miyamoto v. Lum and Lazo, 84 P.3d 509 (2004).

4. Rosenberg v. Jing Jiang, 153 A.D.3d 744 (2017).

5. Wallman v. Kelley, 976 P.2d 330 (1998).

6. Charell v. Gonzales, 673 N.Y.S. 2d 685 (1998).

7. Gonzales v. NYS DOH, 232 A.D.2d 886 (1996).

8. Schneider v. Revici, 817 F. 2d 987 (1987).

Pages

Recommended Reading

Terminating an employee
MDedge Endocrinology
Conservatism spreads in prostate cancer
MDedge Endocrinology
Survey: Health care costs, access unlikely to improve in 2019
MDedge Endocrinology
Fund projects, not people to address gender bias in research funding
MDedge Endocrinology
ONC aims to help docs, patients with information sharing in proposed rule
MDedge Endocrinology
How are you at coping with transparency?
MDedge Endocrinology
Lower prices drive OTC insulin sales at Walmart
MDedge Endocrinology
Culture change needed to improve gender inequalities in medicine
MDedge Endocrinology
A prescription for medicine’s gender inequality
MDedge Endocrinology
McAneny: Transparency needed for meaningful talk on drug pricing
MDedge Endocrinology